How can we chop CML with an ASXL1?
- PMID: 41343167
- DOI: 10.1182/blood.2025031031
How can we chop CML with an ASXL1?
Comment on
-
Impact of ASXL1 at diagnosis in patients with CML receiving frontline potent TKIs: high risk of kinase domain mutations.Blood. 2025 Dec 4;146(23):2821-2832. doi: 10.1182/blood.2025030259. Blood. 2025. PMID: 40896831
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
